Nel ASA Faces a Defining Quarter as Orders Surge, Cash Ebbs, and Wall Street Cools

Nel ASA faces revenue decline despite record order intake; JPMorgan trims target to NOK 1.80, highlighting cash burn and leadership uncertainty.

The arithmetic at Nel ASA has become brutally simple: demand is roaring, revenue is retreating, and the balance sheet is quietly doing the heavy lifting while investors wait for the two curves to finally cross.

That tension came into sharp focus in early August when JPMorgan trimmed its twelve-month price target on the Norwegian hydrogen specialist to NOK 1.80, down from NOK 2.90. The bank held its "Hold" rating, and in a telling nuance, explicitly acknowledged the company's strong order intake even as it dialed back expectations on how quickly the sector reaches profitability. It was a move that captures the broader schizophrenia surrounding this stock — the market sees the momentum, but it also sees the burn rate.

The share price response has been muted, which itself says something. The stock changed hands at €0.1982 on the day of the JPMorgan update, down 0.60 percent, and continues to trade well beneath its 50-day moving average of €0.2184. That persistent gap points to an intact short-term downtrend, with the shares still roughly 46 percent off the 52-week high of €0.3655 touched in late May.

A Quarter of Contradictions

The disconnect JPMorgan flagged was on full display in the company's second-quarter report, released in mid-July. Revenue came in at NOK 153 million, a 12 percent decline from the NOK 174 million posted in the same period a year earlier. Yet order intake exploded 224 percent to NOK 230 million, lifting the total order backlog to NOK 1.213 billion.

That widening gap between invoiced sales and incoming demand is the central puzzle. The order book is filling up, but it has not yet translated into the top line — and the company's cash position tells a parallel story of attrition. Nel held NOK 1.328 billion in liquid reserves as of June 30, down from NOK 1.928 billion twelve months prior. Roughly NOK 600 million has evaporated over the course of a year, underscoring how heavily the company continues to lean on its capital cushion while it waits for the order surge to mature into profitable growth.

The second quarter also brought a product milestone. Nel moved its pressurized alkaline platform, the PA-Series, into commercial marketing — a step designed to broaden the order base in the quarters ahead. Whether that platform can generate repeat orders remains an open question, but it gives the company a fresh product story to tell alongside the backlog numbers.

Leadership Vacancy and Legal Closure

Complicating the narrative is an unresolved leadership question. Håkon Volldal announced his resignation as President & CEO roughly a month ago, citing a desire to pursue other opportunities. He remains in place during a six-month notice period while the board conducts a search for his successor. The stock has shed about 1.6 percent since the announcement — a reaction that suggests the market views the transition as manageable rather than alarming, though it adds an element of uncertainty to the autumn months.

June also brought the conclusion of a legal dispute with Iwatani Corporation of America. Nel settled the matter with a final payment of NOK 70 million — a sum that further dented the cash position but at least removes a lingering overhang.

On the ownership front, there are signals worth watching. Board Chairman Arvid Moss purchased 100,000 shares in April at an average price of NOK 2.2547, establishing his first position in the company. According to a disclosure from early June, the largest shareholders include custodian Clearstream Banking with 67.72 percent, Samsung E&A with 9.09 percent, and CACEIS Bank with 1.77 percent.

A Market in Wait-and-See Mode

The equity market has responded to all of this with a tentative stabilization rather than conviction. The stock closed Friday at €0.1994, up 1.63 percent on the day and 1.84 percent on the week — a modest recovery attempt that leaves the shares still 6.95 percent below their 200-day average. The market capitalization hovers around €361 million, a figure that remains vulnerable to the sector's inherent volatility.

The picture is one of a company in transition: operational progress on one side, a capital market waiting for confirmation on the other. The liquidity position of roughly NOK 1.3 billion buys time, but it buys no guarantees.

All roads now lead to October 21, when Nel publishes its third-quarter interim report. That will be the moment of truth — whether the second quarter's order surge finally begins showing up in revenue, and whether the PA-Series platform can generate the follow-on demand that would validate the company's commercial strategy. Until then, the shares are likely to keep oscillating between the optimism of the backlog and the caution of the cash burn, with JPMorgan's trimmed target serving as a sober reminder of how long the road to profitability may still be.